Organism name | Clausena excavata |
---|---|
Genus | Clausena |
Family | Rutaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Clausena excavata |
---|---|
Linked NCBI taxonomy ID | 76959 |
Linked level | species |
Family in NCBI taxonomy | Rutaceae |
---|---|
ID | 23513 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00013982
![]() |
Myricetin 3',4'-dimethyl ether 3-rhamnoside
/ 3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-4H-1-benzopyran-4-one |
No. 2 | No. 15 |
![]() |
||||
C00000977
![]() |
Liquiritigenin
|
CHEMBL252642
CHEMBL271939 |
C083152
|
5 / 4 / 4 | 1 / 1 | No. 25 | No. 14 |
![]() |
C00006925
![]() |
Isoliquiritigenin
|
CHEMBL129795
CHEMBL1395334 |
C040920
|
59 / 83 / 90 | 12 / 3 | No. 92 | No. 13 |
![]() |
C00026896
![]() |
Clausine-P
/ Clausine P |
No. 239 |
![]() |
|||||
C00026897
![]() |
Clausine-Q
/ Clausine Q |
No. 239 |
![]() |
|||||
C00024710
![]() |
Glycozolidal
|
CHEMBL2036045
|
No. 239 |
![]() |
||||
C00001753
![]() |
Murrayanine
|
CHEMBL1689802
|
No. 239 |
![]() |
||||
C00025140
![]() |
2-Hydroxy-3-formyl-7-methoxycarbazole
|
CHEMBL463264
|
No. 239 |
![]() |
||||
C00026902
![]() |
Clausine-V
/ 2,7-Dimethoxycarbazole / 2,7-Dimethoxy-9H-carbazole |
No. 239 |
![]() |
|||||
C00024731
![]() |
Murrayafolin A
|
CHEMBL490667
|
No. 239 |
![]() |
||||
C00039185
![]() |
Excavatin A
/ (+)-Excavatin A |
No. 335 |
![]() |
|||||
C00025172
![]() |
Heptaphylline
|
CHEMBL1689799
|
No. 437 |
![]() |
||||
C00026899
![]() |
Clausine-S
/ (+)-Clausine S |
No. 437 |
![]() |
|||||
C00030473
![]() |
Heptazoline
|
No. 437 |
![]() |
|||||
C00026903
![]() |
Clausenatine A
|
No. 437 |
![]() |
|||||
C00002488
![]() |
Osthol
/ Osthole |
CHEMBL52229
|
C046627
|
12 / 6 / 5 | 7 / 4 | No. 466 | No. 25 |
![]() |
C00036889
![]() |
Cedrelopsin
|
No. 466 | No. 25 |
![]() |
||||
C00039189
![]() |
Excavatin F
|
No. 590 |
![]() |
|||||
C00039190
![]() |
Excavatin H
|
No. 590 |
![]() |
|||||
C00039191
![]() |
Excavatin I
/ (+)-Excavatin I |
No. 590 |
![]() |
|||||
C00039188
![]() |
Excavatin D
/ (+)-Excavatin D |
CHEMBL1348986
|
4 / 13 / 8 | No. 590 |
![]() |
|||
C00029988
![]() |
Clauslactone M
|
No. 590 |
![]() |
|||||
C00035269
![]() |
Clauslactone E
|
CHEMBL488603
|
No. 590 |
![]() |
||||
C00030242
![]() |
Excavatin E
|
No. 590 |
![]() |
|||||
C00046676
![]() |
Clauslactone I
/ (+)-Clauslactone I |
CHEMBL470443
|
No. 590 |
![]() |
||||
C00030243
![]() |
Excavatin G
|
No. 590 |
![]() |
|||||
C00039192
![]() |
Excavatin J
/ (+)-Excavatin J |
CHEMBL470443
|
No. 590 |
![]() |
||||
C00002505
![]() |
Xanthyletin
|
CHEMBL303846
|
C020814
|
29 / 43 / 58 | No. 750 | No. 25 |
![]() |
|
C00032520
![]() |
Xanthoxyletin
|
CHEMBL501358
|
14 / 5 / 7 | No. 750 | No. 25 |
![]() |
||
C00038258
![]() |
3-Methylcarbazole
|
CHEMBL1173768
|
C110004
|
1 / 1 / 0 | No. 751 |
![]() |
||
C00026895
![]() |
Clausine-O
/ Clausine O |
CHEMBL1689804
|
No. 751 |
![]() |
||||
C00024676
![]() |
3-Formylcarbazole
|
CHEMBL1172392
|
1 / 1 / 0 | No. 751 |
![]() |
|||
C00024718
![]() |
Mukonal
|
CHEMBL1077147
|
No. 751 |
![]() |
||||
C00046678
![]() |
Clauszoline M
|
No. 751 |
![]() |
|||||
C00046673
![]() |
Clauslactone F
/ (+)-Clauslactone F |
CHEMBL488604
|
No. 797 |
![]() |
||||
C00046677
![]() |
Clauslactone J
/ (+)-Clauslactone J |
CHEMBL485784
|
No. 797 |
![]() |
||||
C00039195
![]() |
Excavatin M
/ (+)-Excavatin M |
CHEMBL470442
|
No. 797 |
![]() |
||||
C00039193
![]() |
Excavatin K
/ (+)-Excavatin K |
No. 797 |
![]() |
|||||
C00039194
![]() |
Excavatin L
|
CHEMBL485784
|
No. 797 |
![]() |
||||
C00046675
![]() |
Clauslactone H
/ (+)-Clauslactone H |
CHEMBL470442
|
No. 797 |
![]() |
||||
C00029989
![]() |
Clauslactone R
|
No. 797 |
![]() |
|||||
C00029990
![]() |
Clauslactone S
/ (+)-Clauslactone S |
No. 797 |
![]() |
|||||
C00038798
![]() |
Clausine R
|
No. 807 |
![]() |
|||||
C00029986
![]() |
Clausine L
|
CHEMBL2037029
|
No. 807 |
![]() |
||||
C00029984
![]() |
Clausine E
/ Clauszoline I |
CHEMBL235934
|
2 / 0 / 0 | No. 807 |
![]() |
|||
C00029983
![]() |
Clausine C
/ Clauszoline L |
CHEMBL1173128
|
1 / 1 / 0 | No. 807 |
![]() |
|||
C00026724
![]() |
Mukonidine
|
CHEMBL1088190
|
No. 807 |
![]() |
||||
C00026898
![]() |
Clausine-R
/ Clausine R |
No. 807 |
![]() |
|||||
C00026818
![]() |
Mukonine
|
CHEMBL236143
|
No. 807 |
![]() |
||||
C00026893
![]() |
Clausine-M
/ Clausine M |
No. 807 |
![]() |
|||||
C00039755
![]() |
Methyl carbazole-3-carboxylate
|
CHEMBL446253
|
1 / 1 / 0 | No. 807 |
![]() |
|||
C00030835
![]() |
Nordentatin
|
C052084
|
No. 953 |
![]() |
||||
C00030116
![]() |
Dentatin
|
CHEMBL552132
|
No. 953 |
![]() |
||||
C00002503
![]() |
Umbelliferon
/ Umbelliferone / 7-Hydroxycoumarin |
CHEMBL51628
|
C031477
|
39 / 33 / 32 | 9 / 0 | No. 1030 | No. 25 |
![]() |
C00026512
![]() |
Clausamine A
|
CHEMBL479682
|
No. 1177 |
![]() |
||||
C00026517
![]() |
Clausevatine E
|
No. 1177 |
![]() |
|||||
C00026518
![]() |
Clausevatine F
|
No. 1177 |
![]() |
|||||
C00026516
![]() |
Clausevatine D
|
No. 1177 |
![]() |
|||||
C00029991
![]() |
Clauslactone T
/ (+)-Clauslactone T |
No. 1856 |
![]() |
|||||
C00035268
![]() |
Clauslactone A
|
CHEMBL485785
|
No. 1856 |
![]() |
||||
C00029987
![]() |
Clauslactone B
/ (+)-Clauslactone B |
CHEMBL485786
|
No. 1856 |
![]() |
||||
C00046671
![]() |
Clauslactone C
/ (+)-Clauslactone C |
CHEMBL519868
|
No. 1856 |
![]() |
||||
C00046672
![]() |
Clauslactone D
/ (+)-Clauslactone D |
CHEMBL488407
|
No. 1856 |
![]() |
||||
C00030796
![]() |
Murrayacoumarin C
|
No. 1856 |
![]() |
|||||
C00039233
![]() |
Furoclausine B
/ (-)-Furoclausine B |
No. 2135 |
![]() |
|||||
C00026900
![]() |
Clausine-T
/ (-)-Clausine T |
No. 2135 |
![]() |
|||||
C00026901
![]() |
Clausine-U
/ (-)-Clausine U |
No. 2135 |
![]() |
|||||
C00038800
![]() |
Clausine W
/ (-)-Clausine W |
No. 2135 |
![]() |
|||||
C00019883
![]() |
Hassanidin
/ Claucavatin A |
No. 2171 |
![]() |
|||||
C00029981
![]() |
Clausarin
|
CHEMBL158198
|
C052085
|
No. 2171 |
![]() |
|||
C00019943
![]() |
Kinocoumarin
|
No. 2171 |
![]() |
|||||
C00038797
![]() |
Claucavatin B
|
No. 2171 |
![]() |
|||||
C00038799
![]() |
Clausine F
|
CHEMBL519276
|
C076712
|
No. 2229 |
![]() |
|||
C00046674
![]() |
Clauslactone G
/ (+)-Clauslactone G |
No. 2977 |
![]() |
|||||
C00019790
![]() |
Anisocoumarin J
|
No. 2977 |
![]() |
|||||
C00029985
![]() |
Clausine K
/ Clauszoline J |
CHEMBL1689806
|
No. 3858 |
![]() |
||||
C00026894
![]() |
Clausine-N
/ Clausine N |
No. 3858 |
![]() |
|||||
C00026598
![]() |
Furoclausine-A
|
No. 3897 |
![]() |
|||||
C00039186
![]() |
Excavatin B
/ (+)-Excavatin B |
No. 5397 |
![]() |
|||||
C00039187
![]() |
Excavatin C
/ (+)-Excavatin C |
No. 5397 |
![]() |
|||||
C00029982
![]() |
Clausenidin
|
No. 6250 |
![]() |
|||||
C00026519
![]() |
Clausevatine G
|
No. 6588 |
![]() |
|||||
C00038701
![]() |
Carbazomarine A
/ (-)-Carbazomarine A |
No. 8447 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002488 C00002503 C00002505 C00006925 C00032520 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002488 C00002505 C00006925 C00032520 | 0 / 0 |
P52732 | Kinesin-like protein KIF11 | Other cytosolic protein | C00024676 C00029983 C00038258 C00039755 | 1 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002503 C00002505 C00032520 C00039188 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002505 C00006925 C00032520 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002488 C00002503 C00006925 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002503 C00002505 C00032520 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002503 C00002505 C00006925 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002503 C00002505 C00032520 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002488 C00002503 C00002505 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002505 C00006925 C00039188 | 4 / 3 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002505 C00032520 C00039188 | 2 / 2 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002503 C00002505 C00032520 | 1 / 2 |
P56817 | Beta-secretase 1 | A1A | C00002488 C00002503 C00002505 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002503 C00002505 C00032520 | 0 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00002488 C00002503 C00006925 | 6 / 4 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002505 C00006925 C00032520 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002488 C00002503 C00002505 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002503 C00002505 C00006925 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002503 C00002505 C00006925 | 3 / 3 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002505 C00032520 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000977 C00006925 | 2 / 2 |
P22303 | Acetylcholinesterase | Hydrolase | C00002503 C00002505 | 1 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002505 C00032520 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002488 C00006925 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002488 C00006925 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002503 C00006925 | 0 / 3 |
P05412 | Transcription factor AP-1 | Transcription Factor | C00000977 C00006925 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002503 C00006925 | 1 / 2 |
Q04206 | Transcription factor p65 | Transcription Factor | C00000977 C00006925 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002505 C00039188 | 7 / 3 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00006925 C00032520 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002488 C00006925 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002505 C00006925 | 7 / 37 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000977 C00006925 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002505 C00006925 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00002503 C00006925 | 2 / 5 |
P39748 | Flap endonuclease 1 | Enzyme | C00002503 C00006925 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002503 C00006925 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00002505 C00006925 | 4 / 2 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00006925 | 1 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002505 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002505 | 4 / 2 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002503 | 0 / 0 |
P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Oxidoreductase | C00002503 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002503 | 0 / 0 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00002503 | 1 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00006925 | 2 / 3 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00006925 | 1 / 8 |
P54132 | Bloom syndrome protein | Enzyme | C00006925 | 1 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00006925 | 0 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002503 | 1 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00006925 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00006925 | 2 / 0 |
P61586 | Transforming protein RhoA | Unclassified protein | C00029984 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00000977 | 2 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00002503 | 4 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00006925 | 5 / 3 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00006925 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002503 | 1 / 1 |
P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | C00006925 | 1 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00006925 | 2 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00006925 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00006925 | 11 / 10 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00006925 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00006925 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00029984 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002503 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002505 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00006925 | 5 / 2 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002503 | 1 / 1 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002503 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002503 | 0 / 0 |
P21802 | Fibroblast growth factor receptor 2 | TK tyrosine-protein kinase TLK subfamily | C00006925 | 9 / 3 |
P11362 | Fibroblast growth factor receptor 1 | Fgfr | C00006925 | 4 / 5 |
Q00796 | Sorbitol dehydrogenase | Enzyme | C00002503 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00006925 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00006925 | 0 / 0 |
P55210 | Caspase-7 | C14 | C00002503 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00006925 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00002505 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00006925 | 2 / 2 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00006925 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00006925 | 1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00006925 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002503 | 5 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00006925 | 0 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00006925 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002488 | 0 / 0 |
P10721 | Mast/stem cell growth factor receptor Kit | Pdgfr | C00006925 | 4 / 3 |
P14618 | Pyruvate kinase PKM | Enzyme | C00006925 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00002503 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00006925 | 0 / 0 |
O14980 | Exportin-1 | Unclassified protein | C00002488 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002503 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00006925 | 1 / 1 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002505 | 4 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002503 | 1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002503 | 3 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00006925 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002503 | 0 / 0 |
P51531 | Probable global transcription activator SNF2L2 | Unclassified protein | C00006925 | 1 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00032520 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002488
C00006925
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002488
C00006925
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002503
C00006925
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00002503
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002503
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002503
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00002503
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002503
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002503
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00006925
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00006925
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00006925
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00006925
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002503
|
8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00002503
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00006925
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00006925
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00006925
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00006925
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00006925
|
2180 | ACSL1, ACS1, FACL1, FACL2, LACS, LACS1, LACS2 | acyl-CoA synthetase long-chain family member 1 (EC:6.2.1.3) |
C00002488
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00002488
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002488
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002488
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00002488
|
1831 | TSC22D3, DIP, DSIPI, GILZ, TSC-22R, hDIP | TSC22 domain family, member 3 |
C00000977
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#207410 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis; abs2 |
P21802
|
#101200 | Apert syndrome |
P21802
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#123790 | Beare-stevenson cutis gyrata syndrome; bstvs |
P21802
|
#614592 | Bent bone dysplasia syndrome; bbds |
P21802
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#123500 | Crouzon syndrome |
P21802
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#606764 | Gastrointestinal stromal tumor; gist |
P10721
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#602089 | Hemangioma, capillary infantile |
P35968
|
#114550 | Hepatocellular carcinoma |
P08581
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#147950 | Hypogonadotropic hypogonadism 2 with or without anosmia; hh2 |
P11362
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#123150 | Jackson-weiss syndrome; jws |
P21802
|
#149730 | Lacrimoauriculodentodigital syndrome; ladd |
P21802
|
#601626 | Leukemia, acute myeloid; aml |
P10721
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#152950 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation; mclmr |
P52732
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#601358 | Nicolaides-baraitser syndrome; ncbrs |
P51531
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#166250 | Osteoglophonic dysplasia; ogd |
P11362
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
#260540 | Parkinson-dementia syndrome |
P10636
|
#101600 | Pfeiffer syndrome |
P11362
P21802 |
#172700 | Pick disease of brain |
P10636
|
#172800 | Piebald trait; pbt |
P10721
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#609579 | Scaphocephaly, maxillary retrusion, and mental retardation |
P21802
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#273300 | Testicular germ cell tumor; tgct |
P10721
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190440 | Trigonocephaly 1; trigno1 |
P11362
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) P08581 (related) P21802 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P08581 (related) P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P10721
(related)
P10721 (marker) |
H00170 | Piebaldism |
P10721
(related)
|
H00023 | Testicular cancer |
P10721
(marker)
|
H00255 | Hypogonadotropic hypogonadism |
P11362
(related)
|
H00443 | Osteoglophonic dysplasia (OD) |
P11362
(related)
|
H00458 | Craniosynostosis |
P11362
(related)
P21802 (related) |
H00516 | Isolated orofacial clefts |
P11362
(related)
|
H01207 | Trigonocephaly |
P11362
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00642 | Lacrimo-auriculo-dento-digital syndrome (LADD) |
P21802
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009120 | Muscle Cramp |
C00006925
C00000977 |
C538231 | Adenocarcinoma of lung |
C00002488
|
D009422 | Nervous System Diseases |
C00006925
|
D001927 | Brain Diseases |
C00006925
|
D003920 | Diabetes Mellitus |
C00002488
|
D006943 | Hyperglycemia |
C00002488
|
D009361 | Neoplasm Invasiveness |
C00002488
|